Closed-Loop Glucose Control: Psychological and Behavioral Considerations Gonder-Frederick
J Diabetes Sci Technol Vol 5, Issue 6, November 2011
25. American Association of Diabetes Educators. AADE Position
Statement: Continuous subcutaneous insulin therapy using a pump.
Diabetes Educ. 2009.
26. Cortina S, Repaske DR, Hood KK. Sociodemographic and psycho-
logical factors associated with continuous subcutaneous insulin
infusion in adolescents with type 1 diabetes. Pediatr Diabetes.
27. O’Connell MA, Cameron FJ. Practical experience with continuous
subcutaneous insulin infusion therapy in a pediatric diabetes
clinic. J Diabetes Sci Technol. 2008;2(1):91–7.
28. Eugster EA, Francis G, Lawson-Wilkins Drug and Therapeutics
Committee. Position statement: Continuous subcutaneous insulin
infusion in very young children with type 1 diabetes. Pediatr.
29. Lenhard MJ, Grafton D, Reeves MD. Continuous subcutaneous
insulin infusion. A comprehensive review of insulin pump therapy.
Arch Intern Med. 2001;161(19):2293–300.
30. Wysocki T, Harris MA, Wilkinson K, Sadler M, Mauras N,
White NH. Self-management competence as a predictor of outcomes
of intensive therapy or usual care in youth with type 1 diabetes.
Diabetes Care. 2003;26(7):2043–7.
31. Cogen FR, Streisand R, Sarin S. Selecting children and adolescents
for insulin pump therapy: Medical and behavioral considerations.
Diabetes Spectr. 2002;15(2):72–5.
32. Pham M. Diabetes: Updated survey on insulin pumps and
continuous glucose monitoring. New York, NY: HSBC Securities
(USA) Inc; 2006 Aug.
33. Pham M, Phung V. Diabetes: Updated survey on insulin pumps
and continuous glucose monitoring. New York, NY: HSBC
Securities (USA) Inc; 2007 Jul.
34. Juvenile Diabetes Research Foundation Continuous Glucose
Monitoring Study Group, Beck RW, Buckingham B, Miller K,
Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C,
Lael L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV.
Factors predictive of use and of benet from continuous glucose
monitoring in type 1 diabetes. Diabetes Care. 2009;32(11):1947–53.
35. Juvenile Diabetes Research Foundation Continuous Glucose
Monitoring Study Group. Eectiveness of continuous glucose
monitoring in a clinical care environment: evidence from the Juvenile
Diabetes Research Foundation continuous glucose monitoring
(JDRF-CGM) trial. Diabetes Care. 2010;33(1):17–22.
36. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Ru N,
Kerr D, Phillip M. Improved glycemic control in poorly controlled
patients with type 1 diabetes using real-time continuous glucose
monitoring. Diabetes Care. 2006;29(12):2730–2.
37. Garg SK, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S,
Jovanovic L. Improvement in glycemic excursions with trans-
cutaneous, real-time continuous glucose sensor: a randomized
controlled trial. Diabetes Care. 2006;29(1):44–50.
38. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1
diabetes during real time continuous glucose monitoring
compared with self monitoring of blood glucose: meta-analysis of
randomized controlled trials using individual patient data. BMJ.
39. Diabetes Research in Children Network (DirecNet) Study Group.
Psychological aspects of continuous glucose monitoring in pediatric
type 1 diabetes. Pediatr Diabetes. 2006;7(1):32–8.
40. Kashmer L, Clarke W, Gurka M, Elchuri S, Nyer M, Gonder-
Frederick L. Predictors of parental interest in continuous glucose
monitoring for children with type 1 diabetes. Diabetes Technol
41. Ritholz M. Is continuous glucose monitoring for everyone?
Consideration of psychosocial factors. Diabetes Spectr. 2008;21(4):287–9.
42. Block JM, Buckingham B: Use of real-time continuous glucose
monitoring technology in children and adolescents. Diabetes
43. Juvenile Diabetes Research Foundation Continuous Glucose
Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW,
Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA,
Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ,
Lael L, Lawrence JM, Lee J, Mauras N, O’Grady M, Ruedy KJ,
Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H,
Wysocki T, Xing D. Continuous glucose monitoring and intensive
treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–76.
44. Ritholz MD, Atakov-Castillo A, Beste M, Beverly EA, Leighton A,
Weinger K, Wolpert H. Psychosocial factors associated with use of
continuous glucose monitoring. Diabet Med. 2010;27(9):1060–5.
45. Chase HP, Messer L. Understanding insulin pumps and continuous
glucose monitors. 2nd ed. Denver, CO: Children’s Diabetes
Foundation; 2010. p. 93–6.
46. Hirsch IB. Clinical review: Realistic expectations and practical use
of continuous glucose monitoring for the endocrinologist. J Clin
Endocrinol Metab. 2009;94(7):2232–8.
47. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N,
Wysocki T, Beck R, Tamborlane W, Ruedy K; Diabetes Research
in Children Network (DirecNet) Study Group. Freestyle Navigator
continuous glucose monitoring system use in children with type 1
diabetes using glargine-based multiple daily dose regimens:
Results of a pilot trial. Diabetes Care. 2008;31(3):525–7.
48. Evert A, Trence D, Catton S, Huynh P. Continuous glucose
monitoring technology for personal use: an educational
program that educates and supports the patient. Diabetes Educ.
2009;35(4):565–7, 571–3, 577–80.
49. Fabiato K, Buse J, Duclos M, Largay J, Izlar C, O’Connell T,
Stallings J, Dungan K. Clinical experience with continuous glucose
monitoring in adults. Diabetes Technol Ther. 2009;11 Suppl 1:S93–S103.
50. Wadwa RP, Fiallo-Scharer R, Vanderwel B, Messer LH, Cobry E,
Chase HP. Continuous glucose monitoring in youth with type 1
diabetes. Diabetes Technol Ther. 2009;11 Suppl 1:S83–91.
51. Scaramuzza AE, Iafusco D, Rabbone I, Bonfanti R, Lombardo F,
Schiani R, Buono P, Toni S, Cherubini V, Zuccotti GV; Diabetes
Study Group of the Italian Society of Paediatric Endocrinology
and Diabetology. Use of integrated real-time continuous glucose
monitoring/insulin pump system in children and adolescents with
type 1 diabetes: a 3-year follow-up study. Diabetes Technol Ther.
52. Fisher LK, Halvorson M. Future developments in insulin pump
therapy: progression from continuous subcutaneous insulin infusion
to a sensor-pump system. Diabetes Educ. 2006;32(1 Suppl):47S–52S.
53. Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R,
Hartmann R, Lange K, Knip M, Danne T. Sensor-augmented pump
therapy from the diagnosis of childhood type 1 diabetes: results of
the Paediatric Onset Study (ONSET) after 12 months of treatment.
54. Conget I, Battelino T, Giménez M, Gough H, Castañeda J,
Bolinder J; SWITCH Study Group. The SWITCH study (sensing
with insulin pump therapy to control HbA(1c)): design and
methods of a randomized controlled crossover trial on sensor-
augmented insulin pump ecacy in type 1 diabetes suboptimally
controlled with pump therapy. Diabetes Technol Ther. 2011;13(1):49–54.
55. Peyrot M, Rubin RR. Patient-reported outcomes for an integrated
real-time continuous glucose monitoring/insulin pump system.
Diabetes Technol Ther. 2009;11(1):57–62.
56. Halvorson M, Capenter S, Kaiserman K, Kaufman FR. A pilot
trial in pediatrics with the sensor-augmented pump: combining
real-time continuous glucose monitoring with the insulin pump.
J Pediatr. 2007;150(1):103–105.e1.